DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury

Guoping Zheng, Yiping Wang, Shi Hua Xiang, Yuet Ching Tay, Huiling Wu, Debbie Watson, Jason Coombes, Gopala K. Rangan, Stephen I. Alexander, David C.H. Harris

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

CC-chemokine-encoding DNA vaccine has been reported to be capable of inducing immunologic memory to corresponding pathogenic self CC-chemokines in animal models of autoimmune disease. This study investigated whether introduction of a foreign T helper epitope into monocyte chemoattractant protein 1 (CCL2) DNA vaccine could boost its immunogenicity by inducing strong neutralizing autoantibody against the pathogenic chemokine CCL2 sufficiently to be protective in a classically nonimmune model of disease, Adriamycin nephropathy (AN). Modification of the CCL2 DNA vaccine by replacing a surface loop region of CCL2 sequence with tetanus toxoid T helper epitope P30 elicited a strong self-specific CCL2 autoantibody production, as well as an IFN-γ-producing T cell cellular response. The increased immunogenicity of modified CCL2 DNA vaccination but not unmodified CCL2 DNA vaccination was protective against functional and structural renal injury in rat AN. The protective effect of the modified CCL2 DNA vaccine was associated with blockade of glomerular and interstitial macrophage recruitment by neutralizing autoantibody against CCL2, which plays a critical role in eliciting renal injury in AN. Therefore, modification with a foreign T helper epitope breaks self-tolerance by inducing a cellular and humoral response against self-protein and provides a strategy to increase the potency of DNA vaccination sufficiently to afford protection in toxin-induced chronic renal disease.

Original languageEnglish (US)
Pages (from-to)465-474
Number of pages10
JournalJournal of the American Society of Nephrology
Volume17
Issue number2
DOIs
StatePublished - Feb 1 2006

Fingerprint

DNA Vaccines
Poisons
Epitopes
Vaccination
Autoantibodies
Doxorubicin
Kidney
CC Chemokines
Chemokine CCL2
DNA
Wounds and Injuries
Immunologic Memory
Self Tolerance
Tetanus Toxoid
Chronic Renal Insufficiency
Autoimmune Diseases
Animal Models
Macrophages
T-Lymphocytes
Proteins

ASJC Scopus subject areas

  • Nephrology

Cite this

DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury. / Zheng, Guoping; Wang, Yiping; Xiang, Shi Hua; Tay, Yuet Ching; Wu, Huiling; Watson, Debbie; Coombes, Jason; Rangan, Gopala K.; Alexander, Stephen I.; Harris, David C.H.

In: Journal of the American Society of Nephrology, Vol. 17, No. 2, 01.02.2006, p. 465-474.

Research output: Contribution to journalArticle

Zheng, Guoping ; Wang, Yiping ; Xiang, Shi Hua ; Tay, Yuet Ching ; Wu, Huiling ; Watson, Debbie ; Coombes, Jason ; Rangan, Gopala K. ; Alexander, Stephen I. ; Harris, David C.H. / DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury. In: Journal of the American Society of Nephrology. 2006 ; Vol. 17, No. 2. pp. 465-474.
@article{78b1db0e26e7464e9adf85bc3b6aacad,
title = "DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against {"}nonimmune{"} toxic renal injury",
abstract = "CC-chemokine-encoding DNA vaccine has been reported to be capable of inducing immunologic memory to corresponding pathogenic self CC-chemokines in animal models of autoimmune disease. This study investigated whether introduction of a foreign T helper epitope into monocyte chemoattractant protein 1 (CCL2) DNA vaccine could boost its immunogenicity by inducing strong neutralizing autoantibody against the pathogenic chemokine CCL2 sufficiently to be protective in a classically nonimmune model of disease, Adriamycin nephropathy (AN). Modification of the CCL2 DNA vaccine by replacing a surface loop region of CCL2 sequence with tetanus toxoid T helper epitope P30 elicited a strong self-specific CCL2 autoantibody production, as well as an IFN-γ-producing T cell cellular response. The increased immunogenicity of modified CCL2 DNA vaccination but not unmodified CCL2 DNA vaccination was protective against functional and structural renal injury in rat AN. The protective effect of the modified CCL2 DNA vaccine was associated with blockade of glomerular and interstitial macrophage recruitment by neutralizing autoantibody against CCL2, which plays a critical role in eliciting renal injury in AN. Therefore, modification with a foreign T helper epitope breaks self-tolerance by inducing a cellular and humoral response against self-protein and provides a strategy to increase the potency of DNA vaccination sufficiently to afford protection in toxin-induced chronic renal disease.",
author = "Guoping Zheng and Yiping Wang and Xiang, {Shi Hua} and Tay, {Yuet Ching} and Huiling Wu and Debbie Watson and Jason Coombes and Rangan, {Gopala K.} and Alexander, {Stephen I.} and Harris, {David C.H.}",
year = "2006",
month = "2",
day = "1",
doi = "10.1681/ASN.2005020164",
language = "English (US)",
volume = "17",
pages = "465--474",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "2",

}

TY - JOUR

T1 - DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury

AU - Zheng, Guoping

AU - Wang, Yiping

AU - Xiang, Shi Hua

AU - Tay, Yuet Ching

AU - Wu, Huiling

AU - Watson, Debbie

AU - Coombes, Jason

AU - Rangan, Gopala K.

AU - Alexander, Stephen I.

AU - Harris, David C.H.

PY - 2006/2/1

Y1 - 2006/2/1

N2 - CC-chemokine-encoding DNA vaccine has been reported to be capable of inducing immunologic memory to corresponding pathogenic self CC-chemokines in animal models of autoimmune disease. This study investigated whether introduction of a foreign T helper epitope into monocyte chemoattractant protein 1 (CCL2) DNA vaccine could boost its immunogenicity by inducing strong neutralizing autoantibody against the pathogenic chemokine CCL2 sufficiently to be protective in a classically nonimmune model of disease, Adriamycin nephropathy (AN). Modification of the CCL2 DNA vaccine by replacing a surface loop region of CCL2 sequence with tetanus toxoid T helper epitope P30 elicited a strong self-specific CCL2 autoantibody production, as well as an IFN-γ-producing T cell cellular response. The increased immunogenicity of modified CCL2 DNA vaccination but not unmodified CCL2 DNA vaccination was protective against functional and structural renal injury in rat AN. The protective effect of the modified CCL2 DNA vaccine was associated with blockade of glomerular and interstitial macrophage recruitment by neutralizing autoantibody against CCL2, which plays a critical role in eliciting renal injury in AN. Therefore, modification with a foreign T helper epitope breaks self-tolerance by inducing a cellular and humoral response against self-protein and provides a strategy to increase the potency of DNA vaccination sufficiently to afford protection in toxin-induced chronic renal disease.

AB - CC-chemokine-encoding DNA vaccine has been reported to be capable of inducing immunologic memory to corresponding pathogenic self CC-chemokines in animal models of autoimmune disease. This study investigated whether introduction of a foreign T helper epitope into monocyte chemoattractant protein 1 (CCL2) DNA vaccine could boost its immunogenicity by inducing strong neutralizing autoantibody against the pathogenic chemokine CCL2 sufficiently to be protective in a classically nonimmune model of disease, Adriamycin nephropathy (AN). Modification of the CCL2 DNA vaccine by replacing a surface loop region of CCL2 sequence with tetanus toxoid T helper epitope P30 elicited a strong self-specific CCL2 autoantibody production, as well as an IFN-γ-producing T cell cellular response. The increased immunogenicity of modified CCL2 DNA vaccination but not unmodified CCL2 DNA vaccination was protective against functional and structural renal injury in rat AN. The protective effect of the modified CCL2 DNA vaccine was associated with blockade of glomerular and interstitial macrophage recruitment by neutralizing autoantibody against CCL2, which plays a critical role in eliciting renal injury in AN. Therefore, modification with a foreign T helper epitope breaks self-tolerance by inducing a cellular and humoral response against self-protein and provides a strategy to increase the potency of DNA vaccination sufficiently to afford protection in toxin-induced chronic renal disease.

UR - http://www.scopus.com/inward/record.url?scp=33645450690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645450690&partnerID=8YFLogxK

U2 - 10.1681/ASN.2005020164

DO - 10.1681/ASN.2005020164

M3 - Article

C2 - 16396966

AN - SCOPUS:33645450690

VL - 17

SP - 465

EP - 474

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 2

ER -